Duke R - Search Results

1

Mutation-specific control of BCR-ABL T315I positive leukemia with a recombinant yeast-based therapeutic vaccine in a murine model.

Bui MR, Hodson V, King T, Leopold D, Dai S, Fiolkoski V, Oakes S, Duke R, Apelian D, Franzusoff A, DeGregori J. Bui MR, et al. Among authors: duke r. Vaccine. 2010 Aug 23;28(37):6028-35. doi: 10.1016/j.vaccine.2010.06.085. Epub 2010 Jul 7. Vaccine. 2010. PMID: 20619375 Free PMC article.

2

Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins.

Haller AA, Lauer GM, King TH, Kemmler C, Fiolkoski V, Lu Y, Bellgrau D, Rodell TC, Apelian D, Franzusoff A, Duke RC. Haller AA, et al. Vaccine. 2007 Feb 9;25(8):1452-63. doi: 10.1016/j.vaccine.2006.10.035. Epub 2006 Nov 10. Vaccine. 2007. PMID: 17098335

3

Mutation-selective tumor remission with Ras-targeted, whole yeast-based immunotherapy.

Lu Y, Bellgrau D, Dwyer-Nield LD, Malkinson AM, Duke RC, Rodell TC, Franzusoff A. Lu Y, et al. Cancer Res. 2004 Aug 1;64(15):5084-8. doi: 10.1158/0008-5472.CAN-04-1487. Cancer Res. 2004. PMID: 15289309

4

Yeasts encoding tumour antigens in cancer immunotherapy.

Franzusoff A, Duke RC, King TH, Lu Y, Rodell TC. Franzusoff A, et al. Expert Opin Biol Ther. 2005 Apr;5(4):565-75. doi: 10.1517/14712598.5.4.565. Expert Opin Biol Ther. 2005. PMID: 15934834 Review.

5

Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity.

Stubbs AC, Martin KS, Coeshott C, Skaates SV, Kuritzkes DR, Bellgrau D, Franzusoff A, Duke RC, Wilson CC. Stubbs AC, et al. Among authors: duke rc. Nat Med. 2001 May;7(5):625-9. doi: 10.1038/87974. Nat Med. 2001. PMID: 11329066

6

Fas ligand-dependent suppression of autoimmunity via recruitment and subsequent termination of activated T cells.

Modiano JF, Sun J, Lang J, Vacano G, Patterson D, Chan D, Franzusoff A, Gianani R, Meech SJ, Duke R, Bellgrau D. Modiano JF, et al. Among authors: duke r. Clin Immunol. 2004 Jul;112(1):54-65. doi: 10.1016/j.clim.2004.03.011. Clin Immunol. 2004. PMID: 15207782

7

A role for CD95 ligand in preventing graft rejection.

Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. Bellgrau D, et al. Among authors: duke rc. Nature. 1995 Oct 19;377(6550):630-2. doi: 10.1038/377630a0. Nature. 1995. PMID: 7566174

8

Isolation of the human PC6 gene encoding the putative host protease for HIV-1 gp160 processing in CD4+ T lymphocytes.

Miranda L, Wolf J, Pichuantes S, Duke R, Franzusoff A. Miranda L, et al. Among authors: duke r. Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7695-700. doi: 10.1073/pnas.93.15.7695. Proc Natl Acad Sci U S A. 1996. PMID: 8755538 Free PMC article.

9

Adenoviral-mediated gene transfer in lymphocytes.

Leon RP, Hedlund T, Meech SJ, Li S, Schaack J, Hunger SP, Duke RC, DeGregori J. Leon RP, et al. Among authors: duke rc. Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13159-64. doi: 10.1073/pnas.95.22.13159. Proc Natl Acad Sci U S A. 1998. PMID: 9789058 Free PMC article.

10

HIV gp120-specific cell-mediated immune responses in mice after oral immunization with recombinant Salmonella.

Berggren RE, Wunderlich A, Ziegler E, Schleicher M, Duke RC, Looney D, Fang FC. Berggren RE, et al. Among authors: duke rc. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Dec 15;10(5):489-95. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 8548327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters